United States:
Top 10 In Law Blogs: FDA Approves Second Biosimilar Drug Since The Biologic Price Competition And Innovation Act Of 2009 Was Passed
11 May 2016
Fox Rothschild LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Jean W. Frydman's blog post, "
FDA Approves Second Biosimilar Drug Since the Biologic Price
Competition and Innovation Act of 2009 Was Passed,"
originally posted in the firm's
Emerging Companies Insider blog, was mentioned as one of the
top postings for May 03, 2016.
View full article
here.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).